Intensified testing for attention-deficit hyperactivity disorder (ADHD) in girls should reduce depression and smoking in adult females and the prevalence of ADHD in the longterm

Medical Hypotheses

Volumn 72, Issue 4, 2009, Pages 409-412

  Pinkhardt, Elmar H ^a   Kassubek, Jan ^a   Brummer, Dagmar ^a   Koelch, Michael ^a   Ludolph, Albert C ^a   Fegert, Joerg M ^a   Ludolph, Andrea G ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; NICOTINE;

ADOLESCENCE; ADULTHOOD; ARTICLE; ATTENTION DEFICIT DISORDER; CHILDHOOD; DELAYED DIAGNOSIS; DEPRESSION; DISEASE ASSOCIATION; DOPAMINERGIC TRANSMISSION; FEMALE; FUNCTIONAL DISEASE; GENETIC PREDISPOSITION; GROUPS BY AGE; HUMAN; NEUROBIOLOGY; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING HABIT;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DEPRESSION; FEMALE; HUMANS; MASS SPECTROMETRY; PREVALENCE; SMOKING;

EID: 60449100613     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.11.025     Document Type: Article

References (57)

1. Barbaresi W.J., Katusic S.K., Colligan R.C., Pankratz V.S., Weaver A.L., Weber K.J., et al. How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester. Minn Arch Pediatr Adolesc Med 156 (2002) 217-224
2. Biederman J., and Faraone S.V. Attention-deficit hyperactivity disorder. Lancet 366 (2005) 237-248
3. Rappley M.D. Clinical practice. Attention-deficit hyperactivity disorder. N Engl J Med 352 (2005) 165-173
4. Arnold L.E. Sex differences in ADHD: conference summary. J Abnorm Child Psychol 24 (1996) 555-569
5. Kessler R.C., Adler L., Barkley R., Biederman J., Conners C.K., Demler O., et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiat 163 (2006) 716-723
6. Biederman J., Faraone S.V., Spencer T., Wilens T., Mick E., and Lapey K.A. Gender differences in a sample of adults with attention-deficit hyperactivity disorder. Psychiat Res 53 (1994) 13-29
7. De Ridder T., Bruffearts R., Danckaerts M., Bonnewyn A., and Demyttenaere K. The prevalence of ADHD in the Belgian general adult population: an epidemiological explanatory study. Tijdschr Psychiat 50 (2008) 499-508
8. Conners C.K. Rating scales in attention-deficit/hyperactivity disorder: use in assessment and treatment monitoring. J Clin Psychiat 59 Suppl 7 (1998) 24-30
9. Biederman J., Faraone S.V., Spencer T., Wilens T., Norman D., Lapey K.A., et al. and psychosocial functioning in adults with attention-deficit hyperactivity disorder. Am J Psychiat 150 (1993) 1792-1798
10. Ludolph A.G., Kassubek J., Schmeck K., Glaser C., Wunderlich A., Buck A.K., et al. 4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study. Neuroimage 41 (2008) 718-727
11. Wilens T.E., Vitulano M., Upadhyaya H., Adamson J., Sawtelle R., Utzinger L., et al. Cigarette smoking associated with attention-deficit hyperactivity disorder. J Pediatr 153 (2008) 414-419
12. Lule D., Ludolph A.C., and Ludolph A.G. Neurodevelopmental and neurodegenerative diseases - is there a pathophysiological link? Attention-deficit/hyperactivity disorder and amyotrophic lateral sclerosis as examples. Med Hypotheses 70 (2008) 1133-1138
13. Faraone S.V., Sergeant J., Gillberg C., and Biederman J. The worldwide prevalence of ADHD: is it an American condition?. World Psychiat 2 (2003) 104-113
14. Froehlich T.E., Lanphear B.P., Epstein J.N., Barbaresi W.J., Katusic S.K., and Kahn R.S. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med 161 (2007) 857-864
15. Abikoff H.B., Jensen P.S., Arnold L.L., Hoza B., Hechtman L., Pollack S., et al. Observed classroom behaviour of children with ADHD: relationship to gender and comorbidity. J Abnorm Child Psychol 30 (2002) 349-359
16. Derks E.M., Hudziak J.J., and Boomsma D.I. Why more boys than girls with ADHD receive treatment: a study of Dutch twins. Twin Res Hum Genet 10 (2007) 765-770
17. Biederman J., Mick E., Faraone S.V., Braaten E., Doyle A., Spencer T., et al. Influence of gender on attention-deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiat 159 (2002) 36-42
18. Wolraich M.L., Hannah J.N., Baumgaertel A., and Feurer I.D. Examination of DSM-IV criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Dev Behav Pediatr 19 (1998) 162-168
19. Robison R.J., Reimherr F.W., Marchant B.K., Faraone S.V., Adler L.A., and West S.A. Gender differences in 2 clinical trials of adults with attention-deficit/hyperactivity disorder: a retrospective data analysis. J Clin Psychiat 69 (2008) 213-221
20. Rucklidge J., Brown D., Crawford S., and Kaplan B. Attributional styles and psychosocial functioning of adults with ADHD: practice issues and gender differences. J Atten Disord 10 (2007) 288-298
21. Angold A., Costello E.J., and Erkanli A. Comorbidity. J Child Psychol Psychiat 40 (1999) 57-87
22. Drabick D.A., Gadow K.D., and Sprafkin J. Co-occurrence of conduct disorder and depression in a clinic-based sample of boys with ADHD. J Child Psychol Psychiat 47 (2006) 766-774
23. Able S.L., Johnston J.A., Adler L.A., and Swindle R.W. Functional and psychosocial impairment in adults with undiagnosed ADHD. Psychol Med 37 (2007) 97-107
24. Bylund D.B., and Reed A.L. Childhood and adolescent depression: why do children and adults respond differently to antidepressant drugs?. Neurochem Int 51 (2007) 246-253
25. Kollins S.H., McClernon F.J., and Fuemmeler B.F. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Arch Gen Psychiat 62 (2005) 1142-1147
26. Kalyva E. Prevalence and influences on self-reported smoking among adolescents with mild learning disabilities, attention-deficit hyperactivity disorder, and their typically developing peers. J Intellect Disabil 11 (2007) 267-279
27. Strong K., Guthold R., Yang J., Lee D., Petit P., and Fitzpatrick C. Tobacco use in the European region. Eur J Cancer Prev 17 (2008) 162-168
28. Pomerleau O.F., Downey K.K., Stelson F.W., and Pomerleau C.S. Cigarette smoking in adult patients diagnosed with attention-deficit hyperactivity disorder. J Subst Abuse 7 (1995) 373-378
29. McClernon F.J., Fuemmeler B.F., Kollins S.H., Kail M.E., and Ashley-Koch A.E. Interactions between genotype and retrospective ADHD symptoms predict lifetime smoking risk in a sample of young adults. Nicotine Tob Res 10 (2008) 117-127
30. Banerjee T.D., Middleton F., and Faraone S.V. Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr 96 (2007) 1269-1274
31. Albayrak O., Friedel S., Schimmelmann B.G., Hinney A., and Hebebrand J. Genetic aspects in attention-deficit/hyperactivity disorder. J Neural Transm 115 (2008) 305-315
32. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., and Monteggia L.M. Neurobiology of depression. Neuron 34 (2002) 13-25
33. Johansen E.B., Aase H., Meyer A., and Sagvolden T. Attention-deficit/hyperactivity disorder (ADHD) behaviour explained by dysfunctioning reinforcement and extinction processes. Behav Brain Res 130 (2002) 37-45
34. Robbins T.W., James M., Owen A.M., Sahakian B.J., Lawrence A.D., McInnes L., et al. J Int Neuropsychol Soc 4 (1998) 474-490
35. Bush G., Valera E.M., and Seidman L.J. Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions. Biol Psychiat 57 (2005) 1273-1284
36. Plessen K.J., Bansal R., Zhu H., Whiteman R., Amat J., Quackenbush G.A., et al. Hippocampus and amygdala morphology in attention-deficit/hyperactivity disorder. Arch Gen Psychiat 63 (2006) 795-807
37. Zetzsche T., Frodl T., Preuss U.W., Schmitt G., Seifert D., Leinsinger G., et al. Amygdala volume and depressive symptoms in patients with borderline personality disorder. Biol Psychiat 60 (2006) 302-310
38. MacQueen G.M., Campbell S., McEwen B.S., Macdonald K., Amano S., Joffe R.T., et al. and hippocampal volume in major depression. Proc Natl Acad Sci U S A 100 (2003) 1387-1392
39. Videbech P., and Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiat 161 (2004) 1957-1966
40. Adams J., Crosbie J., Wigg K., Ickowicz A., Pathare T., Roberts W., et al. N-methyl D-aspartate 2A (GRIN2A) gene as a positional candidate for attention-deficit/hyperactivity disorder in the 16p13 region. Mol Psychiat 9 (2004) 494-499
41. Perlov E., Philipsen A., Hesslinger B., Buechert M., Ahrendts J., Feige B., et al. Reduced cingulate glutamate/glutamine-to-creatine ratios in adult patients with attention-deficit hyperactivity disorder - a magnet resonance spectroscopy study. J Psychiat Res 41 (2007) 934-941
42. Sagvolden T., Johansen E.B., Aase H., and Russell V.A. A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav Brain Sci 28 (2005) 397-419 [discussion 419-368]
43. Russell V.A. The nucleus accumbens motor-limbic interface of the spontaneously hypertensive rat as studied in vitro by the superfusion slice technique. Neurosci Biobehav Rev 24 (2000) 133-136
44. Nestler E.J., and Carlezon Jr. W.A. The mesolimbic dopamine reward circuit in depression. Biol Psychiat 59 (2006) 1151-1159
45. Durand D., Pampillo M., Caruso C., and Lasaga M. Role of metabotropic glutamate receptors in the control of neuroendocrine function. Neuropharmacology 55 (2008) 577-583
46. Goksoyr P.K., and Nottestad J.A. The burden of untreated ADHD among adults: the role of stimulant medication. Addict Behav 33 (2008) 342-346
47. Volkow N.D., Wang G.J., Newcorn J., Telang F., Solanto M.V., Fowler J.S., et al. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiat 64 (2007) 932-940
48. Slotkin T.A. Fetal nicotine or cocaine exposure: which one is worse?. J Pharmacol Exp Ther 285 (1998) 931-945
49. Tsai S.J. Attention-deficit hyperactivity disorder may be associated with decreased central brain-derived neurotrophic factor activity: clinical and therapeutic implications. Med Hypotheses 68 (2007) 896-899
50. Smith M.A., Makino S., Kvetnansky R., and Post R.M. Effects of stress on neurotrophic factor expression in the rat brain. Ann NY Acad Sci 771 (1995) 234-239
51. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., and Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioural models of depression. J Neurosci 22 (2002) 3251-3261
52. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., and Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiat 50 (2001) 260-265
53. Aleisa A.M., Alzoubi K.H., Gerges N.Z., and Alkadhi K.A. Chronic psychosocial stress-induced impairment of hippocampal LTP: possible role of BDNF. Neurobiol Dis 22 (2006) 453-462
54. Kahn R.S., Khoury J., Nichols W.C., and Lanphear B.P. Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive, and oppositional behaviors. J Pediatr 143 (2003) 104-110
55. Linnet K.M., Dalsgaard S., Obel C., Wisborg K., Henriksen T.B., Rodriguez A., et al. Maternal lifestyle factors in pregnancy risk of attention-deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am J Psychiat 160 (2003) 1028-1040
56. Obel C., Linnet K.M., Henriksen T.B., Rodriguez A., Jarvelin M.R., Kotimaa A., et al. Smoking during pregnancy and hyperactivity-inattention in the offspring--comparing results from three Nordic cohorts. Int J Epidemiol (2008)
57. Gehricke J.G., Whalen C.K., Jamner L.D., Wigal T.L., and Steinhoff K. The reinforcing effects of nicotine and stimulant medication in the everyday lives of adult smokers with ADHD: a preliminary examination. Nicotine Tob Res 8 (2006) 37-47